Moleculin Biotech
MBRX
MBRX
16 hedge funds and large institutions have $1.95M invested in Moleculin Biotech in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, reducing their positions, and 6 closing their positions.
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$0 |
2 |
2
BlackRock
New York
|
$0 |
3 |
3
Goldman Sachs
New York
|
$0 |
4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$0 |